Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis

Current Biology

Volumn 17, Issue 14, 2007, Pages 1212-1218

  Muise, Aleixo M ^a   Walters, Thomas ^a   Wine, Eytan ^a   Griffiths, Anne M ^a   Turner, Dan ^a   Duerr, Richard H ^c   Regueiro, Miguel D ^c   Ngan, Bo Yee ^b   Xu, Wei ^a   Sherman, Philip M ^a   Silverberg, Mark S ^a   Rotin, Daniela ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

CELLIMMUNO; HUMDISEASE; SIGNALING

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; COLON; ENZYMOLOGY; EXON; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MALE; METABOLISM; MOUSE; MOUSE MUTANT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ALTERNATIVE SPLICING; ANIMALS; BETA CATENIN; BIOLOGICAL MARKERS; CADHERINS; COLITIS, ULCERATIVE; COLON; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2;

MUS;

EID: 34447306637     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2007.06.013     Document Type: Article

References (35)

1. Wallace M.J., Batt J., Fladd C.A., Henderson J.T., Skarnes W., and Rotin D. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma. Nat. Genet. 21 (1999) 334-338
2. Elchebly M., Wagner J., Kennedy T.E., Lanctot C., Michaliszyn E., Itie A., Drouin J., and Tremblay M.L. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat. Genet. 21 (1999) 330-333
3. Batt J., Asa S., Fladd C., and Rotin D. Pituitary, pancreatic and gut neuroendocrine defects in protein tyrosine phosphatase-sigma-deficient mice. Mol. Endocrinol. 16 (2002) 155-169
4. Van der Sluis M., De Koning B.A., De Bruijn A.C., Velcich A., Meijerink J.P., Van Goudoever J.B., Buller H.A., Dekker J., Van Seuningen I., Renes I.B., and Einerhand A.W. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006) 117-129
5. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., and Buchler M.W. Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion 62 (2000) 240-248
6. Hansen K.K., Sherman P.M., Cellars L., Andrade-Gordon P., Pan Z., Baruch A., Wallace J.L., Hollenberg M.D., and Vergnolle N. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc. Natl. Acad. Sci. USA 102 (2005) 8363-8368
7. van der Waaij L.A., Harmsen H.J., Madjipour M., Kroese F.G., Zwiers M., van Dullemen H.M., de Boer N.K., Welling G.W., and Jansen P.L. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: Commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm. Bowel Dis. 11 (2005) 865-871
8. Fouquet S., Lugo-Martinez V.H., Faussat A.M., Renaud F., Cardot P., Chambaz J., Pincon-Raymond M., and Thenet S. Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J. Biol. Chem. 279 (2004) 43061-43069
9. Joseph R.R., Yazer E., Hanakawa Y., and Stadnyk A.W. Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18. Apoptosis 10 (2005) 1221-1233
10. Siu R., Fladd C., and Rotin D. N-Cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTP{sigma}) and participates in PTP{sigma}-mediated inhibition of axon growth. Mol. Cell. Biol. 27 (2007) 208-219
11. Flint A.J., Tiganis T., Barford D., and Tonks N.K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 94 (1997) 1680-1685
12. Jankowski J.A., Bedford F.K., Boulton R.A., Cruickshank N., Hall C., Elder J., Allan R., Forbes A., Kim Y.S., Wright N.A., and Sanders D.S. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab. Invest. 78 (1998) 1155-1167
13. Karayiannakis A.J., Syrigos K.N., Efstathiou J., Valizadeh A., Noda M., Playford R.J., Kmiot W., and Pignatelli M. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J. Pathol. 185 (1998) 413-418
14. Hermiston M.L., and Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270 (1995) 1203-1207
15. Luber B., Candidus S., Handschuh G., Mentele E., Hutzler P., Feller S., Voss J., Hofler H., and Becker K.F. Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate. Cell Adhes. Commun. 7 (2000) 391-408
16. Roura S., Miravet S., Piedra J., Garcia de Herreros A., and Dunach M. Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J. Biol. Chem. 274 (1999) 36734-36740
17. Hu P., O'Keefe E.J., and Rubenstein D.S. Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin. J. Invest. Dermatol. 117 (2001) 1059-1067
18. Kinch M.S., Clark G.J., Der C.J., and Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J. Cell Biol. 130 (1995) 461-471
19. Liu D., el-Hariry I., Karayiannakis A.J., Wilding J., Chinery R., Kmiot W., McCrea P.D., Gullick W.J., and Pignatelli M. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab. Invest. 77 (1997) 557-563
20. Staddon J.M., Herrenknecht K., Smales C., and Rubin L.L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell Sci. 108 (1995) 609-619
21. Hermiston M.L., and Gordon J.I. In vivo analysis of cadherin function in the mouse intestinal epithelium: Essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129 (1995) 489-506
22. Hermiston M.L., Wong M.H., and Gordon J.I. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 10 (1996) 985-996
23. Vrees M.D., Pricolo V.E., Potenti F.M., and Cao W. Abnormal motility in patients with ulcerative colitis: The role of inflammatory cytokines. Arch. Surg. 137 (2002) 439-445
24. Kozaiwa K., Sugawara K., Smith Jr. M.F., Carl V., Yamschikov V., Belyea B., McEwen S.B., Moskaluk C.A., Pizarro T.T., Cominelli F., and McDuffie M. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 125 (2003) 477-490
25. Wagner J., Gordon L.A., Heng H.H., Tremblay M.L., and Olsen A.S. Physical mapping of receptor type protein tyrosine phosphatase sigma (PTPRS) to human chromosome 19p13.3. Genomics 38 (1996) 76-78
26. Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., McLeod R.S., Griffiths A.M., Green T., Brettin T.S., Stone V., Bull S.B., et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66 (2000) 1863-1870
27. van Heel D.A., Fisher S.A., Kirby A., Daly M.J., Rioux J.D., and Lewis C.M. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet. 13 (2004) 763-770
28. van Heel D.A., Dechairo B.M., Dawson G., McGovern D.P., Negoro K., Carey A.H., Cardon L.R., Mackay I., Jewell D.P., and Lench N.J. The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. Hum. Mol. Genet. 12 (2003) 2569-2575
29. Tello-Ruiz M.K., Curley C., DelMonte T., Giallourakis C., Kirby A., Miller K., Wild G., Cohen A., Langelier D., Latiano A., et al. Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur. J. Hum. Genet. 14 (2006) 780-790
30. van Bodegraven A.A., Curley C.R., Hunt K.A., Monsuur A.J., Linskens R.K., Onnie C.M., Crusius J.B., Annese V., Latiano A., Silverberg M.S., et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 131 (2006) 1768-1774
31. Purcell S., Daly M.J., and Sham P.C. WHAP: Haplotype-based association analysis. Bioinformatics 23 (2007) 255-256
32. Endo N., Rutledge S.J., Opas E.E., Vogel R., Rodan G.A., and Schmidt A. Human protein tyrosine phosphatase-sigma: Alternative splicing and inhibition by bisphosphonates. J. Bone Miner. Res. 11 (1996) 535-543
33. Lajus S., and Lang J. Splice variant 3, but not 2 of receptor protein-tyrosine phosphatase sigma can mediate stimulation of insulin-secretion by alpha-latrotoxin. J. Cell. Biochem. 98 (2006) 1552-1559
34. Lynch K.W., and Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276 (2001) 24341-24347
35. Jacobsen M., Schweer D., Ziegler A., Gaber R., Schock S., Schwinzer R., Wonigeit K., Lindert R.B., Kantarci O., Schaefer-Klein J., et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26 (2000) 495-499